The Early/Expanded Access Committee has informed me that four additional sites have been added to the trial so there are now 23 States that have an expanded access trial of MDV3100 available to men with advanced prostate cancer. The trial is designed to monitor the safety of the drug in men with progressive castration-resistant advanced prostate cancer previously treated with Docetaxel based chemotherapy.

The new sites are located in Abington Pennsylvania, Santa Rosa California, Portland Oregon and Washington DC.

This trial will provide men with advanced prostate cancer who qualify access to MDV3100 prior to a final approval decision from the FDA. In this trial there will NOT be any placebo as well as no cost for the MDV3100/ enzalutamide (check with trial site for any other costs).
Basic Eligibility Criteria:

CRPC/HRPC – on hormone therapy with progressive disease
3 weeks since taking Zytiga (abiraterone).
Previously treated with Taxotere (docetaxel)
No small cell or neuroendocrine features.
No brain metastases.
No history of stroke or seizure.
No significant cardiovascular disease.
HGB 9.0 or higher.

If you think you fit this Basic Eligibility Criteria, contact one of the sites below for further screening.

Alaska Clinical Research Center, LLC
Contact: Robin Adams (907) 276-1455
Anchorage, Alaska 99508

Pinnacle Oncology/Hematology
Contact: Sherril Bierman (480) 278-8804
Scottsdale, AZ 85258

Prostate Oncology Specialists
Contact: Jennifer Leung (310) 827-7707
Marina del Rey, CA 90292

Dr Ronald Yanagihara
Contact: Katrina or Lara (408) 847-6194
Gilroy, CA 95020
Tower Urology/ Tower Research Institute
Contact:  Maria Reyes (310) 854-9898  x160
Los Angeles, CA  90048
Stanford University Cancer Ctr
Contact:  Denise Haas (650) 736-1252
Palo Alto, CA  94304

Redwood Regional Medical Group
Contact:  Jackie Malin (707) 521-3836
Santa Rosa, CA  95403

Ocala Oncology Center
Contact:  Amy Liebman (352) 732-4938
Ocala, FL  34471

PeachTree Hematology Oncology Consultants
Contact: Ann Johnston (678) 298-3241
Atlanta, GA
Northwest Georgia Oncology Centers
Contact:  Mary Gilley (770) 281-5131
Marietta, GA  30060

Illinois Cancer Care
Contact: Lori Lynch  (309) 243-3627
Peoria, IL 61615

Investigative Clinical Research of Indiana LLC
Contact: Leslie Weitman (317) 716-0323
Indianapolis, IN 46260
Metairie Oncologist
Contact:  Lucy Cousin  (504) 885-0577 x 317
Metairie, LA  70006

Jackson Oncology Associates PLLC
Contact: Teresa Davis (601) 974-5547
Jackson, Mississippi 39202
Nebraska Hematology Oncology
Contact:  Ashley Waldred (402) 484-4908
Lincoln, NE  68506
Comprehensive Cancer Centers of Nevada
Contact:  Ann Lovelace (702) 952-3400 x 5414
Las Vegas, NV  89169

New Hampshire
New Hampshire Oncology Hematology PA
Contact: Margaret White (603) 224-2556 x 1323
Hooksett, New Hampshire, 03106

New York
Accumed Research Associates
Contact: Tammi Allegra (516) 746-2190
Garden City, New York, 11530
Associated Medical Professionals of New York
Contact:  Tonya Godfrey  (315) 706-8112
Syracuse, NY  13210

North Carolina
Cancer Centers of North Carolina
Contact: Julia Berry (919) 781-7070
Raleigh, North Carolina 27607
Tulsa Cancer Institute
Contact:  Sharon Franklin  (918) 292-8085
Tulsa, OK  74136
Tulsa Southwestern Regional Med Ctr
Contact:  Jennifer Dvorak  (918) 286-5448
Tulsa, OK  74133
Oregon Urology Institute
Contact: Stephanie Kerns  (541) 284-5508
Eugene, OR  97477
Oregon Health & Science University
Contact:  Kristi Eilers  (503) 494-2897
Portland, OR  97239

University of Pennsylvania
Contact:  Jenelle Robinson  (215) 662-7398
Philadelphia, PA  19104
Abington Memorial Hospital
Contact:  Mabry Sondra  (215) 481-2402
Abington, PA  19001
South Carolina
Charleston Hematology Oncology Associates, PA
Contact: Deborah McNeal (843) 266-2540
Charleston, South Carolina, 29414

Carolina Urologic Research Center
Contact: Tabitha Joyner (843) 449-1010 x228
Myrtle Beach, South Carolina, 29572

The Jones Clinic, PC
Contact: Morgan Medus (901) 685-5969 x322
Germantown, TN 38138
UT Southwestern Medical Ctr
Contact:  Allison Beaver  (214) 645-5921
Dallas, TX  75390

Virginia Oncology Associates
Contact: Wendi Gobhardt (757) 213-5813
Norfolk, VA, 23502
Northwest Medical Specialties
Contact:  Linda Dheane (253) 302-2896
Tacoma, WA  98405
Washington DC
George Washington Univ
Contact:  Hiwot Guebre-Xabiher  (202) 741-2981
Washington DC, 20037
* Enrollment Tip – ?It often takes a few weeks to complete the enrollment and screening process for an expanded access trial. You may be able to speed up this process
by supplying the clinical trial nurse with your own medical records, which may relieve him/her from trying to obtain them from another clinic. Factor all of this into your decisions. As always, discuss with your physician(s) the pros and cons of your participating in this or any other clinical trial.

Joel T. Nowak, M.A, M.S.W.